FDA Drug Information Update on Valsartan Products

PUBLISHED: Sep 25, 2018
Relevant to: Ambulatory Care, Critical Access Hospitals, Hospitals, Medical Office, Rural Health Clinics

The U.S. Food and Drug Administration (FDA) has updated the list of valsartan products not under recall with five Teva products that were not previously on either list.

FDA reminds patients taking valsartan from a recalled lot that they should continue taking their current medicine until their doctor or pharmacist provides a replacement or a different treatment option. Not all valsartan products contain NDMA, so pharmacists may be able to provide a refill of valsartan medication not affected by the recall, or doctors may prescribe a different medication that treats the same condition.

Follow the link below for additional information.

Want to read the full alert and receive alert emails?

Browse Additional Alerts